# TRAT1

## Overview
TRAT1, or T cell receptor associated transmembrane adaptor 1, is a gene that encodes a type III transmembrane protein crucial for immune function. The protein encoded by TRAT1 is predominantly expressed in human T lymphocytes and natural killer (NK) cells, where it plays a pivotal role in T-cell receptor (TCR) signaling. As a transmembrane adaptor protein, TRAT1 is involved in the regulation of TCR expression and function, contributing to the structural integrity of the TCR/CD3 complex. It facilitates the shuttling of CTLA-4 from the trans Golgi network to the T-cell surface, which is essential for stabilizing the TCR and CD3 complex, thereby influencing T-cell activation and antigen-specific responses. TRAT1's involvement in various signaling pathways, including those related to cancer progression, highlights its significance in both immune regulation and potential clinical applications, particularly in the context of lung adenocarcinoma and canine epitheliotropic lymphoma (Xiao2022TRAT1; Olayinka2023Cathepsin).

## Function
TRAT1 (T cell receptor associated transmembrane adaptor 1) is a type III transmembrane protein expressed by human T lymphocytes and natural killer (NK) cells. It plays a crucial role in regulating T-cell receptor (TCR) expression and function. Structurally, TRAT1 consists of an extracellular domain, a transmembrane region, and a cytosolic tail, which are essential for its function in TCR signaling (Olayinka2023Cathepsin).

In healthy human cells, TRAT1 facilitates the shuttling of CTLA-4 from the trans Golgi network to the T-cell surface. This process is vital for stabilizing the TCR and CD3 complex, which is necessary for effective T-cell activation and antigen-specific responses. The presence of TRAT1 contributes to the structural integrity of the TCR/CD3 complex, thereby playing a significant role in TCR functions (Olayinka2023Cathepsin).

TRAT1's involvement in TCR signaling impacts the immune response by facilitating signal transduction in T cells. This protein is primarily located in the plasma membrane, where it is crucial for the activation and function of T cells, influencing immune system regulation and response (Olayinka2023Cathepsin).

## Clinical Significance
The TRAT1 gene has significant clinical implications, particularly in the context of lung adenocarcinoma (LAC) and canine epitheliotropic lymphoma (EL). In LAC, elevated TRAT1 expression is associated with a tumor-suppressive role, inhibiting cell growth, metastasis, and promoting apoptosis. Decreased expression of TRAT1 is linked to poor prognosis, affecting overall survival and progression-free survival in patients. It is also correlated with clinical factors such as smoking history and PD-L1 expression, indicating its potential as a prognostic biomarker (Xiao2022TRAT1).

In canine EL, TRAT1 serves as a sensitive and specific RNA biomarker, distinguishing EL from other interface dermatitis conditions. Its expression shows significant sensitivity and specificity in diagnostic settings, suggesting its utility in early diagnosis and treatment initiation. The study of TRAT1 in canine EL also highlights similarities with human cutaneous T-cell lymphoma (CTCL), suggesting potential cross-species diagnostic applications (Olayinka2023Cathepsin).

Overall, alterations in TRAT1 expression levels are crucial in the progression and prognosis of certain cancers, and its role in immune infiltration and signaling pathways underscores its importance in cancer biology and potential therapeutic targeting (Xiao2022TRAT1; Olayinka2023Cathepsin).

## Interactions
TRAT1, or T cell receptor associated transmembrane adaptor 1, is a protein that plays a significant role in T cell receptor (TCR) signaling. It is involved in the regulation of TCR expression and function, contributing to the structural integrity of the TCR/CD3 complex. TRAT1 facilitates the shuttling of CTLA-4 from the trans Golgi network to the T-cell surface, which is crucial for stabilizing the T-cell antigen receptor and CD3 complex. This interaction is important for modulating T-cell responses, including cytokine release mediated by CTLA-4 (Olayinka2023Cathepsin).

In lung adenocarcinoma (LAC), TRAT1 is associated with several signaling pathways, including the TCR signaling pathway, and is involved in the differentiation of Th1, Th2, and Th17 cells. It is also linked to the Toll-like receptor, VEGF, MAPK, and MTOR signaling pathways, which are related to cancer progression (Xiao2022TRAT1). The protein-protein interaction (PPI) network of TRAT1 co-expressed genes indicates its role in cancer mechanisms and immunity, suggesting that TRAT1 interacts with various proteins involved in these pathways (Xiao2022TRAT1). These interactions highlight TRAT1's potential as a regulatory gene in cancer progression and its association with the immune microenvironment in LAC.


## References


[1. (Xiao2022TRAT1) Xiao-Yue Xiao, Qiang Guo, Song Tong, Chuang-Yan Wu, Jiu-Ling Chen, Yu Ding, Jun-Hao Wan, Shan-Shan Chen, and Si-Hua Wang. Trat1 overexpression delays cancer progression and is associated with immune infiltration in lung adenocarcinoma. Frontiers in Oncology, October 2022. URL: http://dx.doi.org/10.3389/fonc.2022.960866, doi:10.3389/fonc.2022.960866. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.960866)

[2. (Olayinka2023Cathepsin) Jadesola Temitope Olayinka, Akanksha Nagarkar, Diana Junyue Ma, Neil B. Wong, Andrew Romasco, Cesar Piedra-Mora, Linda Wrijil, Clement N. David, Heather L. Gardner, Nicholas A. Robinson, Kelly L. Hughes, Bruce Barton, Cheryl A. London, Ram√≥n M. Almela, and Jillian M. Richmond. Cathepsin w, t-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor k1 are sensitive and specific rna biomarkers of canine epitheliotropic lymphoma. Frontiers in Veterinary Science, November 2023. URL: http://dx.doi.org/10.3389/fvets.2023.1225764, doi:10.3389/fvets.2023.1225764. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fvets.2023.1225764)